Showing results (1211-1220 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|June 7, 2019
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literatureCassandra Calabrese, Laura C Cappelli, Marie Kostine, et al.
RMD Open|June 7, 2019
Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adultsMaria G Tektonidou, Laura Andreoli, Marteen Limper, et al.
RMD Open|October 2, 2018
Cross-sectional survey of the undergraduate rheumatology curriculum in European medical schools: a EULAR School of Rheumatology initiativeAbhishek Abhishek, Annamaria Iagnocco, J W J Bijlsma, et al.
RMD Open|April 19, 2019
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical featuresAnna-Maria Hoffmann-Vold, Oliver Distler, Baron Murray, et al.
RMD Open|April 19, 2019
MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositisTaro Ukichi, Ken Yoshida, Satoshi Matsushima, et al.
RMD Open|April 19, 2019
Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54Rieke Alten, Bogdan Batko, Tomas Hala, et al.
RMD Open|April 1, 2022
Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDsJames M Gwinnutt, Maud Wieczorek, Giulio Cavalli, et al.
RMD Open|March 17, 2022
Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trialCatherine Beauvais, Françoise Fayet, Alexandra Rousseau, et al.
RMD Open|March 17, 2022
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd studyDésirée van der Heijde, Lianne S Gensler, Walter P Maksymowych, et al.
RMD Open|March 24, 2022
Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomesIain B McInnes, Laura M Sawyer, Kristen Markus, et al.
Pageof 197